TIS21 functions as an anti-proliferative transcriptional cofactor in fibroblast cells (NIH3T3), mouse embryo fibroblasts, breast cancer cells, prostate cancer cells and hepatocellular carcinoma (HCC) cells [17, 24–26]. Here, BTG2 is linked to breast cancer.